A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma

被引:0
|
作者
Horvat, Natally [1 ]
Andrieu, Pamela Causa [1 ]
Meier, Andreas [2 ]
Ji, Xinge [3 ]
Lakhman, Yulia [1 ]
Soslow, Robert [4 ]
Allison, Douglas [4 ]
Gangai, Natalie [1 ]
Rodriguez, Lee [1 ]
Kattan, Michael W. [3 ]
Chi, Dennis S. [5 ]
Hricak, Hedvig [1 ,6 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10065 USA
[2] Univ Hosp Zurich, Dept Radiol, Ramistr 100, CH-8091 Zurich, Switzerland
[3] Cleveland Clin, Dept Quantitat Hlth Sci, 9500 Euclid Ave, Cleveland, OH 44195 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, 1275 York Ave, New York, NY 10065 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Radiol, 417 E 68th St,Room Z-2064, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
Ovarian neoplasms; Nomograms; Multidetector computed tomography; COMPUTED-TOMOGRAPHY; FROZEN-SECTION; CANCER; STAGE; PROGNOSIS; SURVIVAL; LYMPHADENECTOMY; ENDOMETRIOSIS; ASSOCIATION; RECURRENCE;
D O I
10.1016/j.ygyno.2023.06.579
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. To evaluate clinical, laboratory, and radiological variables from preoperative contrast-enhanced computed tomography (CECT) for their ability to distinguish ovarian clear cell carcinoma (OCCC) from nonOCCC and to develop a nomogram to preoperatively predict the probability of OCCC.Methods. This IRB-approved, retrospective study included consecutive patients who underwent surgery for an ovarian tumor from 1/1/2000 to 12/31/2016 and CECT of the abdomen and pelvis & LE;90 days before primary debulking surgery. Using a standardized form, two experienced oncologic radiologists independently analyzed imaging features and provided a subjective 5-point impression of the probability of the histological diagnosis. Nomogram models incorporating clinical, laboratory, and radiological features were created to predict histological diagnosis of OCCC over non-OCCC. Results. The final analysis included 533 patients with surgically confirmed OCCC (n = 61) and non-OCCC (n = 472); history of endometriosis was more often found in patients with OCCC (20% versus 3.6%; p < 0.001), while CA-125 was significantly higher in patients with non-OCCC (351 ng/mL versus 70 ng/mL; p < 0.001). A nomogram model incorporating clinical (age, history of endometriosis and adenomyosis), laboratory (CA-125) and imaging findings (peritoneal implant distribution, morphology, laterality, and diameter of ovarian lesion and of the largest solid component) had an AUC of 0.9 (95% CI: 0.847, 0.949), which was comparable to the AUCs of the experienced radiologists' subjective impressions [0.8 (95% CI: 0.822, 0.891) and 0.9 (95% CI: 0.865, 0.936)].Conclusions. A presurgical nomogram model incorporating readily accessible clinical, laboratory, and CECT variables was a powerful predictor of OCCC, a subtype often requiring a distinctive treatment approach. & COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [31] Ovarian clear cell carcinoma - An examination of relapses
    Nguyen, P.
    Wong, F.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 225 - 226
  • [32] Napsin A as a marker of clear cell ovarian carcinoma
    Skirnisdottir, Ingiridur
    Bjersand, Kathrine
    Akerud, Helena
    Seidal, Tomas
    BMC CANCER, 2013, 13
  • [33] Chromosomal abnormalities in ovarian clear cell carcinoma
    Dent, J
    Perren, T
    Wilkinson, N
    Richmond, I
    Markham, A
    Bell, S
    BRITISH JOURNAL OF CANCER, 2001, 85 : 73 - 73
  • [34] Ovarian Clear Cell Carcinoma in Cowden Syndrome
    Yauy, Kevin
    Imbert-Bouteille, Marion
    Bubien, Virginie
    Lindet-Bourgeois, Clothilde
    Rathat, Gauthier
    Perrochia, Helene
    MacGrogan, Gaetan
    Longy, Michel
    Bessis, Didier
    Tinat, Julie
    Baert-Desurmont, Stephanie
    Blanluet, Maud
    Vande Perre, Pierre
    Baudry, Karen
    Pujol, Pascal
    Corsini, Carole
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (01): : 7 - 11
  • [35] A CLEARER VIEW ON OVARIAN CLEAR CELL CARCINOMA
    De Pauw, Aglaja
    Naert, Eline
    Van de Vijver, Koen
    Philippe, Tummers
    Vandecasteele, Katrien
    Denys, Hannelore
    ACTA CLINICA BELGICA, 2022, 77 (04) : 792 - 804
  • [36] Molecular pathogenesis of ovarian clear cell carcinoma
    Gounaris, Ioannis
    Brenton, James D.
    FUTURE ONCOLOGY, 2015, 11 (09) : 1389 - 1405
  • [37] Development and validation of a prognostic nomogram for ovarian clear cell carcinoma: a study based on the SEER database and a Chinese cohort
    Yao Shen
    Fei Xi
    Pingge Zhao
    Yuhang Zhang
    Guanlin Guo
    Xueyuan Jia
    Jie Wu
    Ye Kuang
    Discover Oncology, 16 (1)
  • [38] Expression of podoplanin in ovarian clear cell carcinoma
    Kotarski, Jozef
    Marzec-Kotarska, Barbara
    Szumilo, Justyna
    Klepacz, Robert
    Cybulski, Marek
    Sobstyl, Malgorzata
    Bednarek, Wieslawa
    GINEKOLOGIA POLSKA, 2011, 82 (05) : 350 - 353
  • [39] New therapies for clear cell ovarian carcinoma
    Stewart, James
    Cunningham, Niamh
    Banerjee, Susana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 385 - 393
  • [40] The target therapy of ovarian clear cell carcinoma
    Jin, Ying
    Li, Yan
    Pan, Lingya
    ONCOTARGETS AND THERAPY, 2014, 7 : 1647 - 1652